Corticosteroids in the treatment of IgA nephropathy: what do we learn from the TESTING trial
IgA nephropathy (IgAN), the most common form of primary glomerulonephritis, is predominant in young adults and children. Corticosteroid therapy has been controversial over several past decades. TESTING (Therapeutic Effects of Steroids in IgA Nephropathy Global) study, initiated in 2012, is an intern...
Saved in:
Main Authors: | Ming-jing Pi (Author), Jing Yuan (Author), Lu Liu (Author), Ping-hong He (Author), Shan-shan Hu (Author), Yan Zha (Author) |
---|---|
Format: | Book |
Published: |
Editorial Department of Journal of Clinical Nephrology,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of corticosteroid therapy in IgA nephropathy; where do we stand?
by: Shankar Prasad Nagaraju, et al.
Published: (2017) -
Corticosteroid therapy in IgA Nephropathy: A friend or foe?
by: Dana Kim, et al.
Published: (2023) -
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
by: Kai Zhang, et al.
Published: (2019) -
Sulodexide in IgA nephropathy
Published: (2013) -
IgA Nephropathy in Czech Patients - Are We Able Reliably Predict the Outcome?
by: Dita Maixnerova, et al.
Published: (2014)